| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Parkman Healthcare Partners LLC last filed a Form 4 in October 2025, as 10% Owner at SPRB.
At the last filing, the largest reported position was 1,050 shares of SPRB. The SPRB filings lean toward selling, a net 2 shares.
Parkman Healthcare Partners LLC has 2 Form 4 filings on record in October 2025, all as 10% Owner at Spruce Biosciences (SPRB), 2025.
The 6 reported transactions were 4 open-market sales and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $9K and 2 sales worth about $10K.
The largest open-market purchase was 256 shares of SPRB at an average $17.91 on October 6, 2025, about $5K. Twelve months later SPRB was down 67%.
The largest open-market sale was 257 shares of SPRB at an average $19.14 on October 6, 2025, about $5K. Twelve months later SPRB was down 67%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | SPRB Spruce Biosciences, Inc. | 10% Owner | Sell | 257 | $19.14 | $4,920.12 | -19.7% | -37.0% | -67.2% | |
| Oct 6, 2025 | SPRB Spruce Biosciences, Inc. | 10% Owner | Buy | 256 | $17.91 | $4,585.16 | +24.4% | -37.0% | -67.2% | |
| Oct 6, 2025 | SPRB Spruce Biosciences, Inc. | 10% Owner | Buy | 256 | $17.91 | $4,585.16 | +24.4% | -37.0% | -67.2% | |
| Oct 6, 2025 | SPRB Spruce Biosciences, Inc. | 10% Owner | Sell | 257 | $19.14 | $4,920.12 | -19.7% | -37.0% | -67.2% |